全文获取类型
收费全文 | 58040篇 |
免费 | 3612篇 |
国内免费 | 1699篇 |
专业分类
耳鼻咽喉 | 395篇 |
儿科学 | 992篇 |
妇产科学 | 689篇 |
基础医学 | 4786篇 |
口腔科学 | 1099篇 |
临床医学 | 5189篇 |
内科学 | 5909篇 |
皮肤病学 | 501篇 |
神经病学 | 3191篇 |
特种医学 | 1313篇 |
外国民族医学 | 6篇 |
外科学 | 5601篇 |
综合类 | 11223篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 5887篇 |
眼科学 | 947篇 |
药学 | 5017篇 |
116篇 | |
中国医学 | 8765篇 |
肿瘤学 | 1720篇 |
出版年
2024年 | 178篇 |
2023年 | 980篇 |
2022年 | 1725篇 |
2021年 | 2444篇 |
2020年 | 2205篇 |
2019年 | 2282篇 |
2018年 | 1981篇 |
2017年 | 1867篇 |
2016年 | 1794篇 |
2015年 | 1540篇 |
2014年 | 3707篇 |
2013年 | 3272篇 |
2012年 | 3339篇 |
2011年 | 4105篇 |
2010年 | 3701篇 |
2009年 | 2744篇 |
2008年 | 2529篇 |
2007年 | 2751篇 |
2006年 | 2523篇 |
2005年 | 2118篇 |
2004年 | 1708篇 |
2003年 | 1587篇 |
2002年 | 1090篇 |
2001年 | 956篇 |
2000年 | 826篇 |
1999年 | 768篇 |
1998年 | 587篇 |
1997年 | 557篇 |
1996年 | 460篇 |
1995年 | 512篇 |
1994年 | 494篇 |
1993年 | 376篇 |
1992年 | 356篇 |
1991年 | 328篇 |
1990年 | 282篇 |
1989年 | 283篇 |
1988年 | 282篇 |
1987年 | 234篇 |
1986年 | 208篇 |
1985年 | 431篇 |
1984年 | 418篇 |
1983年 | 334篇 |
1982年 | 362篇 |
1981年 | 358篇 |
1980年 | 344篇 |
1979年 | 312篇 |
1978年 | 275篇 |
1977年 | 251篇 |
1976年 | 183篇 |
1975年 | 108篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
6.
《Journal of pediatric surgery》2023,58(5):856-861
Background/PurposeA small number of Hirschsprung disease (HD) patients develop inflammatory bowel disease (IBD)-like symptoms after pullthrough surgery. The etiology and pathophysiology of Hirschsprung-associated IBD (HD-IBD) remains unknown. This study aims to further characterize HD-IBD, to identify potential risk factors and to evaluate response to treatment in a large group of patients.MethodsRetrospective study of patients diagnosed with IBD after pullthrough surgery between 2000 and 2021 at 17 institutions. Data regarding clinical presentation and course of HD and IBD were reviewed. Effectiveness of medical therapy for IBD was recorded using a Likert scale.ResultsThere were 55 patients (78% male). 50% (n = 28) had long segment disease. Hirschsprung-associated enterocolitis (HAEC) was reported in 68% (n = 36). Ten patients (18%) had Trisomy 21. IBD was diagnosed after age 5 in 63% (n = 34). IBD presentation consisted of colonic or small bowel inflammation resembling IBD in 69% (n = 38), unexplained or persistent fistula in 18% (n = 10) and unexplained HAEC >5 years old or unresponsive to standard treatment in 13% (n = 7). Biological agents were the most effective (80%) medications. A third of patients required a surgical procedure for IBD.ConclusionMore than half of the patients were diagnosed with HD-IBD after 5 years old. Long segment disease, HAEC after pull through operation and trisomy 21 may represent risk factors for this condition. Investigation for possible IBD should be considered in children with unexplained fistulae, HAEC beyond the age of 5 or unresponsive to standard therapy, and symptoms suggestive of IBD. Biological agents were the most effective medical treatment.Level of EvidenceLevel 4 相似文献
7.
8.
9.
目的:探讨中西医结合治疗对单纯疱疹病毒性角膜炎(HSK)患者视力恢复及血清微量元素的影响。方法:选取2015年1月至2016年10月内蒙古包钢医院收治的HSK患者86例作为研究对象,按照随机数字表法随机分为对照组和观察组,每组43例。对照组采用更昔洛韦滴眼液及硫酸软骨素滴眼液治疗,观察组在对照组基础上结合清肝明目汤进行治疗,2组均连续治疗4周。比较2组患者临床疗效;比较治疗前后2组患者视力恢复状况、血清微量元素及泪液免疫因子水平。结果:治疗后,观察组治疗有效率显著高于对照组,差异有统计学意义(P0.05);治疗后观察组患者视觉模拟评分及视力均显著高于治疗前与对照组,差异有统计学意义(P0.05);治疗后观察组铁离子、钙离子及铜离子水平低于治疗前与对照组,差异有统计学意义(P0.05);血清锌离子水平明显高于治疗前与对照组(P0.05),差异有统计学意义(P0.05);治疗后观察组患者泪液IgA、IgG及C3水平明显高于治疗前与对照组,差异有统计学意义(P0.05)。结论:中西医结合治疗HSK有效促进患者视力的恢复,调节血清微量元素的同时增强患者泪液免疫因子水平,疗效显著优于单用西药治疗。 相似文献
10.
Tonya J.H. White 《Journal of the American Academy of Child and Adolescent Psychiatry》2019,58(11):1042-1050